Warming Up the Cold: A New Hope for Immunotherapy in Prostate Cancer
Ok, Phase 1 data were encouraging, but the sample was small, only 35 patients. But 21% had a PSA decline > 30%, which is not bad at all compared to the usual...
Ok, Phase 1 data were encouraging, but the sample was small, only 35 patients. B...